N = 195 | |
---|---|
Characteristic | |
 Age, mean (SD), years | 52 (21.4) |
 Women, n (%) | 132 (67.7) |
 Asset index quintiles, n (%) | |
  Poorest | 33 (16.9) |
  Poorer | 32 (16.4) |
  Average | 34 (17.4) |
  Rich | 38 (19.5) |
  Richest | 34 (12.3) |
  Missing | 24 (12.3) |
 Highest education level attained, n (%) | |
  None | 73 (37.4) |
  Primary | 105 (53.9) |
  Secondary & Tertiary | 17 (8.7) |
 Smoking history, n (%) | |
  Never smoked | 153 (78.5) |
  Former smoker | 24 (12.3) |
  Current smoker | 18 (9.2) |
 Alcohol use history, n (%) | |
  Never | 19 (9.7) |
  Non-hazardous | 172 (88.2) |
  Hazardous | 4 (2.1) |
Comorbid diseases | |
 Hypertension, n (%) | 56 (28.7) |
 Diabetes mellitus, n (%) | 15 (7.7) |
 HIV infection, n (%) | 16 (8.2) |
 None | 108 (55.4) |
 Self-reported poor medication adherence | 115 (59) |
Aetiology of Heart failure | |
 Hypertensive heart disease | 42 (21.5) |
 Dilated cardiomyopathies | 39 (20.0) |
 Ischemic heart disease | 6 (3.1) |
 Unknown | 108 (55.4) |
NYHAÂ¥ functional class at enrollment | |
 NYHA class I, n (%) | 0 (0) |
 NYHA class II, n (%) | 1 (0.5) |
 NYHA class III, n (%) | 85 (43.6) |
 NYHA class IV, n (%) | 109 (55.9) |
Left ventricular ejection fraction (LVEF) | |
 LVEF*, mean (SD) | 41 (12.9) |
Medication during hospital stay*, n (%) | |
 Furosemide | 178 (91.3) |
 ACEI/ARB∧ | 54 (27.7) |
 Digoxin | 45 (23.1) |
 Dobutamine | 20 (10.3) |
Blood test | |
 Blood urea nitrogen (mg/dL), mean (SD) | 59.6 (65.4) |
 Serum Creatinine (mg/dL), mean (SD) | 2.0 (2.7) |
 Serum sodium (mmol/L), mean (SD) | 132 (15.8) |
 BNP∞(pg/mL), mean (SD) | 2164 (1762) |
 CKMB€ (ng/mL), mean (SD) | 4.3 (10.2) |